Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Populations most affected by RA are also growing younger and broader since 1990.

Rheumatoid Arthritis Burden Has Surged Over Last 30 Years

Depressive symptoms in the first 2 years after diagnosis were linked to lower odds of achieving remission in both RA and PsA.

Depression Reduces Remission Likelihood in Rheumatoid, Psoriatic Arthritis

Investigators call for faster diagnosis and better treatment for psoriatic arthritis to avoid unnecessary complication and suffering.

Study Finds Diagnostic Delay, Less Intensive Therapy Use in PsA than RA

The Phase 2b RENOIR trial met its primary endpoint and key secondary endpoints in patients with RA in new 12-week data.

Rosnilimab Demonstrates Historic Responses for Rheumatoid Arthritis

Tocilizumab-anoh will be available in both intravenous and subcutaneous formulations. 

Tocilizumab Biosimilar Approved for Rheumatological Diseases, COVID-19 

Tocilizumab and other biological drugs were particularly efficacious in lowering overall hemostatic potential, mitigating blood clot risks.

Early Control of Rheumatoid Arthritis Improves Hemostatic Imbalance

Around 37% of those had never used a bDMARD reached sustained DMARD-free remission at 5 years, 

DMARD-Free Remission Feasible for bDMARD-Naive Patients for RA 

Despite improvements in PROs and disease activity, no statistically significant changes have been seen on blood biomarker analysis. 

Cannabinoid-Based Formula Demonstrates Proof-of-Concept for Treating RA 

Cell therapy, particularly CAR-T, is expanding into autoimmune diseases like lupus and multiple sclerosis. While promising, safety, efficacy, and broad applicability remain uncertain.

Leveling Up: Cell Therapy Research Expands Horizons in Autoimmune Disease

Emapalumab may improve outcomes in patients with MAS whose disease didn’t respond to steroid therapy and mitigate the need for more toxic therapies.

Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome

The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.